z-logo
open-access-imgOpen Access
In vitro culture conditions, antiphospholipid antibodies and trophoblast function
Author(s) -
Christine A. Clark,
Carl A. Laskin
Publication year - 2015
Publication title -
human reproduction update
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.977
H-Index - 180
eISSN - 1362-4946
pISSN - 1355-4786
DOI - 10.1093/humupd/dmv005
Subject(s) - trophoblast , in vitro , antibody , function (biology) , andrology , medicine , immunology , pregnancy , biology , microbiology and biotechnology , genetics , placenta , fetus
Sir, We thank Drs Clark and Laskin for their interest in our recently published systematic review of the effects of antiphospholipid antibodies on cultured placental cells in vitro. We agree with many of the authors’ comments and their suggestions for future investigations. However, in suggesting that trophoblast plugs prevent antiphospholipid antibodies accessing the placenta in early gestation, we believe that Drs Clark and Laskin have misinterpreted the reports of trophoblast plugs in the uterine spiral arteries. Firstly, it has been shown that potentially as few as 20% of spiral arteries are fully plugged during the first trimester of human pregnancy (Meekins et al., 1997), which if true, means maternal blood-borne antibodies would readily access early gestation placentae. Secondly, trophoblast plugs in the spiral arteries are widely agreed to be only loosely cohesive (Boyd and Hamilton, 1970; Ramsey and Donner, 1980). This loose cohesion means that while the plugs prevent the passage of maternal red blood cells into the intervillous space, maternal plasma may still pass through the plugs to access the placenta. Supporting this, hysteroscopic examination reveals that placental villi are bathed in a clear fluid prior to 12 weeks of gestation (Jaffe et al., 1997) and histologic specimens of implantation sites from as early as 50 days gestation show clear tracks of fluid leading from the spiral arteries to the intervillous space (Burton et al., 1999). The flow of maternal plasma to and from the placenta is corroborated by the finding of substantial numbers of placenta-derived extracellular vesicles (syncytial nuclear aggregates, microand nanovesicles) in the maternal peripheral blood from as early as 6 weeks of gestation (Covone et al., 1984; Knight et al., 1998; Askelund and Chamley, 2011; Salomon et al., 2014). Thus, unlike maternal red blood cells, soluble factors including antiphospholipid antibodies have access to the first trimester placenta despite the presence of trophoblast plugs in the spiral arteries. Therefore, these autoantibodies may have direct deleterious effects on the placenta from the beginning of placental development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom